Mental health. To map the richness of experience and initiatives in mental health promotion, mental disorder prevention and social inclusion of people with mental health problems in countries at national, regional and local levels, identify and support credible leaders in the health sector and identify gaps in evidence where a need for further research exists.

The EC's important role in health policy has been reaffirmed in the Reform Treaty which was agreed by EU Heads of State and Government in Lisbon on 19 October 2007, and which proposes to reinforce the political importance of health.

[21] The Health Systems Working Party of Health and Consumer Protection DG consists of Project leaders from projects in the field of health systems under the Public health Programme and the previous 8 public health programmes.

With regard to the OPs for which the ESF is lead Fund (employment, education, and health), the Monitoring Committees for those programmes, as part of their powers, adopted the annual reports and made minor amendments to the programme complements which did not require amendment of the OPs.

(6) The Council in its Conclusions of 26 November 1998 on the future framework for Community action in the field of public health(17), and in its Resolution of 8 June 1999(18), the Economic and Social Committee, in its opinion of 9 September 1998(19), the Committee of the Regions, in its Opinion of 19 November 1998(20), and the European Parliament, in its Resolution A4-0082/99 of 12 March 1999(21), welcomed the Commission communication of 15 April 1998 and supported the view that actions at Community level should be set out in one overall programme to run for a period of at least five years and comprising three general objectives, namely ...[+++] improving information for the development of public health, reacting rapidly to health threats and tackling health determinants through health promotion and disease prevention, underpinned by inter-sectoral action and the use of all appropriate Treaty instruments.

Somatotrophin is produced only to enhance milk production, and the EU’s Scientific Committee on Animal Health and Animal Welfare (which was replaced by the European Food Safety Authority, established under Regulation (EC) No 178/2002) stated in March 1999 that the hormone increased the risk of infections and could adversely affect reproduction and induce severe reactions in cattle.